Biotin is vitamin B7. There is a group in France studying Biotin. They published a small study a few months ago, and a larger study was presented at the AAN meeting last month. The results of the study were reported to show a benefit in patients with primary or secondary progressive MS. There were 154 patient enrolled in this study, half on biotin and half on placebo. The outcome measured was the number of people who improved on their disability at 9 months and who continued to be improved at 12 months. 13% improved in the biotin group compared to none in the placebo group. While this is encouraging, this has to be viewed with caution. First, it is surprising that there would be improvement after only 9 months since the nervous system is very slow to heal. Also, only 13 patients improved. This low number improving suggests that the biotin was not helpful for the majority of patients, but it also brings into question whether the results could be due to difficulties with study design such as inadequate numbers of patients or problems with blinding of the treatment/placebo arms. A larger study with a phase III design will be needed to determine whether biotin is truly helpful. This would need to include outcomes such as MRI, eye examinations or evoked potentials to demonstrate that any improvement was actually due to healing of the nervous system.
Most Recent Articles
What to know about the Delta variant: Infectious disease experts weigh in
The COVID-19 Delta variant is quickly becoming the most common strain in the U.S. Discover how you can stay safe and protect your loved ones.
Caring for BIPOC and minority mental health
Access mental health resources at Swedish, and in our community
Depression before and after birth: You are not alone
Millions of women struggle with anxiety, depression and mental health issues during pregnancy and after childbirth. Find ways to cope.
Investing in our community to change lives
Learn why Swedish partners with local organizations to bring critical services into communities where help is needed most.
Do you know how to protect your skin from the summer sun?
Learn how to enjoy the sun safely – including how to protect against skin cancers such as melanoma – with these tips.
Lifting COVID-19 restrictions: Q&A with Swedish experts
With more people in Washington getting vaccinated, restrictions are lifting. Our experts discuss how to keep yourself and others safe.
Are you languishing?
Feeling a little blergh? Neither good nor sad and sort of on autopilot? Get tips from a behavioral health specialist to move from languishing to flourishing.
Pride Month Caregiver Spotlights
We're spotlighting some of our amazing caregivers and sharing what Pride Month means to them.
A cancer survivor's quest to help others beat chemo brain
National Cancer Survivors Day honors people like Katie Henry, who joined the VIBE study at Swedish to beat chemo brain. Here’s her story and memory strategies, too.
New research brings hope for detecting and preventing Alzheimer’s disease
A new blood test to detect Alzheimer’s disease is on the horizon, and recent research shows how you can lower your risk for the disease.
Working toward more compassionate and inclusive care for the LGBTQIA+ community
Learn how Swedish is taking steps to create a safer and more inclusive environment for gender-diverse patients through its LGBTQI+ Initiative.
Have you been putting off your annual men’s wellness exam?
What better way to celebrate Men’s Health Month than by scheduling much needed (and often dreaded) healthcare appointments?
Let us continue on the journey toward equity and justice
A statement from our chief diversity, equity, and inclusion officer
After massive heart attack, ECMO saved Vivek's life
Swedish is one of only two hospitals in Washington to offer novel therapy that allows heart and lungs to rest and heal